Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
Kristin E CoxMichael A TurnerThinzar M LwinSiamak AmirfakhriKaitlyn J KellyMojgan HosseiniPradipta GhoshMarygorret ObonyoRobert M HoffmanPaul J YazakiMichael BouvetPublished in: Annals of surgical oncology (2024)
Humanized anti-CEA (M5A) antibodies conjugated to fluorescent dyes provide bright and specific labeling of gastric cancer PDOX models. This tumor-specific fluorescent antibody is a promising potential clinical tool to detect the extent of disease for the determination of resectability as well as to visualize tumor margins during gastric cancer resection.